These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15549675)

  • 21. A SAS macro for sample size adjustment and randomization test for internal pilot study.
    Wang S; Xia J; Yu L; Li C; Xu L
    Comput Methods Programs Biomed; 2008 Apr; 90(1):66-88. PubMed ID: 18192069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design options for molecular epidemiology research within cohort studies.
    Rundle AG; Vineis P; Ahsan H
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1899-907. PubMed ID: 16103435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of case-control age-at-onset data using a modified case-cohort method.
    Nan B; Lin X
    Biom J; 2008 Apr; 50(2):311-20. PubMed ID: 18318038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials.
    Lai TL; Shih MC; Zhu G
    Stat Med; 2006 Apr; 25(7):1149-67. PubMed ID: 16189814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementing type I & type II error spending for two-sided group sequential designs.
    Rudser KD; Emerson SS
    Contemp Clin Trials; 2008 May; 29(3):351-8. PubMed ID: 17933592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequentially testing for a gene-drug interaction in a genomewide analysis.
    Kelly P; Zhou Y; Whitehead J; Stallard N; Bowman C
    Stat Med; 2008 May; 27(11):2022-34. PubMed ID: 17979181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flexible designs for genomewide association studies.
    Scherag A; Hebebrand J; Schäfer H; Müller HH
    Biometrics; 2009 Sep; 65(3):815-21. PubMed ID: 19173695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomes.
    Hu M; Cappelleri JC; Lan KK
    Clin Trials; 2007; 4(4):329-40. PubMed ID: 17848494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bayesian analysis of misclassified binary data from a matched case-control study with a validation sub-study.
    Prescott GJ; Garthwaite PH
    Stat Med; 2005 Feb; 24(3):379-401. PubMed ID: 15565740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accounting for error due to misclassification of exposures in case-control studies of gene-environment interaction.
    Zhang L; Mukherjee B; Ghosh M; Gruber S; Moreno V
    Stat Med; 2008 Jul; 27(15):2756-83. PubMed ID: 17879261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining data from 2 nested case-control studies of overlapping cohorts to improve efficiency.
    Salim A; Hultman C; Sparén P; Reilly M
    Biostatistics; 2009 Jan; 10(1):70-9. PubMed ID: 18550564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Logistics and design issues in the use of biological samples in observational epidemiology.
    Potter JD
    IARC Sci Publ; 1997; (142):31-7. PubMed ID: 9354909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased power to detect gene-environment interaction using siblings controls.
    Andrieu N; Dondon MG; Goldstein AM
    Ann Epidemiol; 2005 Oct; 15(9):705-11. PubMed ID: 16157257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal spending functions for asymmetric group sequential designs.
    Anderson KM
    Biom J; 2007 Jun; 49(3):337-45. PubMed ID: 17623339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A population-based nested case control study on recurrent pneumonias in children with severe generalized cerebral palsy: ethical considerations of the design and representativeness of the study sample.
    Veugelers R; Calis EA; Penning C; Verhagen A; Bernsen R; Bouquet J; Benninga MA; Merkus PJ; Arets HG; Tibboel D; Evenhuis HM
    BMC Pediatr; 2005 Jul; 5():25. PubMed ID: 16029493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiplicity and flexibility in clinical trials.
    Brannath W; Koenig F; Bauer P
    Pharm Stat; 2007; 6(3):205-16. PubMed ID: 17674349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multivariate survival analysis for case-control family data.
    Hsu L; Gorfine M
    Biostatistics; 2006 Jul; 7(3):387-98. PubMed ID: 16368774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimized multi-stage designs controlling the false discovery or the family-wise error rate.
    Zehetmayer S; Bauer P; Posch M
    Stat Med; 2008 Sep; 27(21):4145-60. PubMed ID: 18444249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tests for gene-environment interaction from case-control data: a novel study of type I error, power and designs.
    Mukherjee B; Ahn J; Gruber SB; Rennert G; Moreno V; Chatterjee N
    Genet Epidemiol; 2008 Nov; 32(7):615-26. PubMed ID: 18473390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.